P

Psioxus Therapeutics

98 employees

Akamis Bio is a clinical-stage oncology company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Immuno-oncology and Re-programming the Tumor Microenvironment
Therapeutics

Date founded

2010

Funding rounds raised

Total raised

$39M

from 16 investors over 16 rounds

P

Psioxus Therapeutics raised $30M on January 5, 2023

Investors: Westlake Village BioPartners®, Parker Institute for Cancer Immunotherapy and ARCH Venture Partners

P

Psioxus Therapeutics raised $30M on January 5, 2023

Investors: Westlake Village BioPartners®, Parker Institute for Cancer Immunotherapy and ARCH Venture Partners

P

Psioxus Therapeutics raised undisclosed on January 18, 2021

Investors: Hambro Perks

P

Psioxus Therapeutics raised $15M on December 12, 2017

Investors: Bristol-Myers Squibb, UK

P

Psioxus Therapeutics raised $39M on May 19, 2015

Investors: Woodford Investment Management, Imperial College London, Lundbeckfonden / Lundbeck Foundation and S.R. One Ltd

P

Psioxus Therapeutics raised $34M on July 9, 2012

Investors: Lundbeckfonden / Lundbeck Foundation, Imperial College London and S.R. One Ltd

P

Psioxus Therapeutics raised $8.5M on March 8, 2010

Investors: Imperial College London

FAQ